Molecular docking analysis and anti-hyperglycaemic activity of Synacinn™ in streptozotocin-induced rats
Nur Syukriah Ab Rahman, Fadzilah Adibah Abdul Majid, Mohd Effendy Abd Wahid, Hassan Fahmi Ismail, Fatahiya Mohamed Tap, Ain Nabihah Zainudin, Siti Nurazwa Zainol, Muzaida Aminah Mohammad
Abstract
dose of Synacinn™ is an effective anti-hyperglycemic agent, lowering blood glucose, triglyceride, and cholesterol levels, and assisting the recovery of organ impairment caused by streptozotocin in type 1 diabetic rats.
Topics & Concepts
StreptozotocinDocking (animal)PharmacologyTraditional medicineChemistryDiabetes mellitusMedicineEndocrinologyVeterinary medicineNatural Antidiabetic Agents StudiesPharmacological Effects of Natural CompoundsBioactive natural compounds